Bod L, Shalapour S. B cells spatial organization defines their phenotype and function in cancer "Tell me with whom you consort, and I will tell you who you are" - Goethe. Current opinion in immunology. 2024;91:102504. doi:10.1016/j.coi.2024.102504
Publications
Ogasawara D, Konrad DB, Tan ZY, et al. Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes. Cell chemical biology. 2024. doi:10.1016/j.chembiol.2024.10.005
Marti-Castellote PM, Reeder C, Claggett BL, et al. Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials. Circulation. Heart failure. 2024. doi:10.1161/CIRCHEARTFAILURE.124.012514
Richard D, Muthuirulan P, Young M, et al. Functional genomics of human skeletal development and the patterning of height heritability. Cell. 2024. doi:10.1016/j.cell.2024.10.040
Wu CS, Hsu CL, Lin MC, et al. Association of polygenic liabilities for schizophrenia and bipolar disorder with educational attainment and cognitive aging. Translational psychiatry. 2024;14(1):472. doi:10.1038/s41398-024-03182-6
Assatova B, Willim R, Trevisani C, et al. KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024;30(11):2514-2530. doi:10.1158/1078-0432.CCR-23-3504
Strausz S, Agafonova E, Tiullinen V, et al. Genetic Analysis of Obstructive Sleep Apnea and Its Relationship with Severe COVID-19. Annals of the American Thoracic Society. 2024;21(6):961-970. doi:10.1513/AnnalsATS.202303-215OC
Balasooriya ER, Wu Q, Ellis H, et al. The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024;30(10):2181-2192. doi:10.1158/1078-0432.CCR-23-3588
Kwok M, Agathanggelou A, Stankovic T. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies. Blood. 2024;143(21):2123-2144. doi:10.1182/blood.2023019963
Hernandez-Lopez P, Vijaykumar T, Anand P, et al. Dual role of signaling pathways in myeloma requires cell type-specific targeting of ligand-receptor interactions. Blood advances. 2024;8(12):3173-3185. doi:10.1182/bloodadvances.2023011463